Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early different-dose Calsurf trial for respiratory distress syndrome in term and late-preterm neonates
ChiCTR-TRC-11001696Phase 4Completed
- Sponsor
- The First Hospital of Jilin University Department of Neonatology
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of calfactant in respiratory distress syndrome (RDS) (2 arms), sponsored by The First Hospital of Jilin University Department of Neonatology. Primary endpoint: Blood gas analysis. Started Jun 2011; status: completed.
02
Drugs
calfactant
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on ChiCTR-TRC-11001696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001696.